Novel epigenetic determinants of type 2 diabetes in Mexican-American families

Hemant Kulkarni, Mark Z. Kos, Jennifer Neary, Thomas D. Dyer, Jack W. Kent, Harald H H Göring, Shelley A. Cole, Anthony G. Comuzzie, Laura Almasy, Michael C. Mahaney, Joanne E. Curran, John Blangero, Melanie A. Carless

    Research output: Contribution to journalArticle

    46 Citations (Scopus)

    Abstract

    Although DNA methylation is now recognized as an important mediator of complex diseases, the extent to which the genetic basis of such diseases is accounted for by DNA methylation is unknown. In the setting of large, extended families representing a minority, high-risk population of the USA, we aimed to characterize the role of epigenome-wide DNA methylation in type 2 diabetes (T2D). Using Illumina HumanMethylation450 BeadChip arrays, we tested for association of DNA methylation at 446 356 sites with age, sex and phenotypic traits related to T2D in 850 pedigreed Mexican-American individuals. Robust statistical analyses showed that (i) 15% of the methylome is significantly heritable, with a median heritability of 0.14; (ii) DNA methylation at 14% of CpG sites is associated with nearby sequence variants; (iii) 22% and 3% of the autosomal CpG sites are associated with age and sex, respectively; (iv) 53 CpG sites were significantly associated with liability to T2D, fasting blood glucose and insulin resistance; (v) DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1 and SAMD12) independently explained 7.8% of the heritability of T2D (vi) methylation at these five sites was unlikely to be influenced by neighboring DNA sequence variation. Our study has identified novel epigenetic indicators of T2D risk in Mexican Americans who have increased risk for this disease. These results provide new insights into potential treatment targets of T2D.

    Original languageEnglish (US)
    Article numberddv232
    Pages (from-to)5330-5344
    Number of pages15
    JournalHuman Molecular Genetics
    Volume24
    Issue number18
    DOIs
    StatePublished - Apr 9 2015

    Fingerprint

    DNA Methylation
    Epigenomics
    Type 2 Diabetes Mellitus
    Mediator Complex
    Methylation
    Insulin Resistance
    Blood Glucose
    Fasting
    Population
    Genes

    ASJC Scopus subject areas

    • Genetics
    • Genetics(clinical)
    • Molecular Biology

    Cite this

    Kulkarni, H., Kos, M. Z., Neary, J., Dyer, T. D., Kent, J. W., Göring, H. H. H., ... Carless, M. A. (2015). Novel epigenetic determinants of type 2 diabetes in Mexican-American families. Human Molecular Genetics, 24(18), 5330-5344. [ddv232]. https://doi.org/10.1093/hmg/ddv232

    Novel epigenetic determinants of type 2 diabetes in Mexican-American families. / Kulkarni, Hemant; Kos, Mark Z.; Neary, Jennifer; Dyer, Thomas D.; Kent, Jack W.; Göring, Harald H H; Cole, Shelley A.; Comuzzie, Anthony G.; Almasy, Laura; Mahaney, Michael C.; Curran, Joanne E.; Blangero, John; Carless, Melanie A.

    In: Human Molecular Genetics, Vol. 24, No. 18, ddv232, 09.04.2015, p. 5330-5344.

    Research output: Contribution to journalArticle

    Kulkarni, H, Kos, MZ, Neary, J, Dyer, TD, Kent, JW, Göring, HHH, Cole, SA, Comuzzie, AG, Almasy, L, Mahaney, MC, Curran, JE, Blangero, J & Carless, MA 2015, 'Novel epigenetic determinants of type 2 diabetes in Mexican-American families', Human Molecular Genetics, vol. 24, no. 18, ddv232, pp. 5330-5344. https://doi.org/10.1093/hmg/ddv232
    Kulkarni H, Kos MZ, Neary J, Dyer TD, Kent JW, Göring HHH et al. Novel epigenetic determinants of type 2 diabetes in Mexican-American families. Human Molecular Genetics. 2015 Apr 9;24(18):5330-5344. ddv232. https://doi.org/10.1093/hmg/ddv232
    Kulkarni, Hemant ; Kos, Mark Z. ; Neary, Jennifer ; Dyer, Thomas D. ; Kent, Jack W. ; Göring, Harald H H ; Cole, Shelley A. ; Comuzzie, Anthony G. ; Almasy, Laura ; Mahaney, Michael C. ; Curran, Joanne E. ; Blangero, John ; Carless, Melanie A. / Novel epigenetic determinants of type 2 diabetes in Mexican-American families. In: Human Molecular Genetics. 2015 ; Vol. 24, No. 18. pp. 5330-5344.
    @article{ddbf110732d945dd8fbbe27920a3b9cc,
    title = "Novel epigenetic determinants of type 2 diabetes in Mexican-American families",
    abstract = "Although DNA methylation is now recognized as an important mediator of complex diseases, the extent to which the genetic basis of such diseases is accounted for by DNA methylation is unknown. In the setting of large, extended families representing a minority, high-risk population of the USA, we aimed to characterize the role of epigenome-wide DNA methylation in type 2 diabetes (T2D). Using Illumina HumanMethylation450 BeadChip arrays, we tested for association of DNA methylation at 446 356 sites with age, sex and phenotypic traits related to T2D in 850 pedigreed Mexican-American individuals. Robust statistical analyses showed that (i) 15{\%} of the methylome is significantly heritable, with a median heritability of 0.14; (ii) DNA methylation at 14{\%} of CpG sites is associated with nearby sequence variants; (iii) 22{\%} and 3{\%} of the autosomal CpG sites are associated with age and sex, respectively; (iv) 53 CpG sites were significantly associated with liability to T2D, fasting blood glucose and insulin resistance; (v) DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1 and SAMD12) independently explained 7.8{\%} of the heritability of T2D (vi) methylation at these five sites was unlikely to be influenced by neighboring DNA sequence variation. Our study has identified novel epigenetic indicators of T2D risk in Mexican Americans who have increased risk for this disease. These results provide new insights into potential treatment targets of T2D.",
    author = "Hemant Kulkarni and Kos, {Mark Z.} and Jennifer Neary and Dyer, {Thomas D.} and Kent, {Jack W.} and G{\"o}ring, {Harald H H} and Cole, {Shelley A.} and Comuzzie, {Anthony G.} and Laura Almasy and Mahaney, {Michael C.} and Curran, {Joanne E.} and John Blangero and Carless, {Melanie A.}",
    year = "2015",
    month = "4",
    day = "9",
    doi = "10.1093/hmg/ddv232",
    language = "English (US)",
    volume = "24",
    pages = "5330--5344",
    journal = "Human Molecular Genetics",
    issn = "0964-6906",
    publisher = "Oxford University Press",
    number = "18",

    }

    TY - JOUR

    T1 - Novel epigenetic determinants of type 2 diabetes in Mexican-American families

    AU - Kulkarni, Hemant

    AU - Kos, Mark Z.

    AU - Neary, Jennifer

    AU - Dyer, Thomas D.

    AU - Kent, Jack W.

    AU - Göring, Harald H H

    AU - Cole, Shelley A.

    AU - Comuzzie, Anthony G.

    AU - Almasy, Laura

    AU - Mahaney, Michael C.

    AU - Curran, Joanne E.

    AU - Blangero, John

    AU - Carless, Melanie A.

    PY - 2015/4/9

    Y1 - 2015/4/9

    N2 - Although DNA methylation is now recognized as an important mediator of complex diseases, the extent to which the genetic basis of such diseases is accounted for by DNA methylation is unknown. In the setting of large, extended families representing a minority, high-risk population of the USA, we aimed to characterize the role of epigenome-wide DNA methylation in type 2 diabetes (T2D). Using Illumina HumanMethylation450 BeadChip arrays, we tested for association of DNA methylation at 446 356 sites with age, sex and phenotypic traits related to T2D in 850 pedigreed Mexican-American individuals. Robust statistical analyses showed that (i) 15% of the methylome is significantly heritable, with a median heritability of 0.14; (ii) DNA methylation at 14% of CpG sites is associated with nearby sequence variants; (iii) 22% and 3% of the autosomal CpG sites are associated with age and sex, respectively; (iv) 53 CpG sites were significantly associated with liability to T2D, fasting blood glucose and insulin resistance; (v) DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1 and SAMD12) independently explained 7.8% of the heritability of T2D (vi) methylation at these five sites was unlikely to be influenced by neighboring DNA sequence variation. Our study has identified novel epigenetic indicators of T2D risk in Mexican Americans who have increased risk for this disease. These results provide new insights into potential treatment targets of T2D.

    AB - Although DNA methylation is now recognized as an important mediator of complex diseases, the extent to which the genetic basis of such diseases is accounted for by DNA methylation is unknown. In the setting of large, extended families representing a minority, high-risk population of the USA, we aimed to characterize the role of epigenome-wide DNA methylation in type 2 diabetes (T2D). Using Illumina HumanMethylation450 BeadChip arrays, we tested for association of DNA methylation at 446 356 sites with age, sex and phenotypic traits related to T2D in 850 pedigreed Mexican-American individuals. Robust statistical analyses showed that (i) 15% of the methylome is significantly heritable, with a median heritability of 0.14; (ii) DNA methylation at 14% of CpG sites is associated with nearby sequence variants; (iii) 22% and 3% of the autosomal CpG sites are associated with age and sex, respectively; (iv) 53 CpG sites were significantly associated with liability to T2D, fasting blood glucose and insulin resistance; (v) DNA methylation levels at five CpG sites, mapping to three well-characterized genes (TXNIP, ABCG1 and SAMD12) independently explained 7.8% of the heritability of T2D (vi) methylation at these five sites was unlikely to be influenced by neighboring DNA sequence variation. Our study has identified novel epigenetic indicators of T2D risk in Mexican Americans who have increased risk for this disease. These results provide new insights into potential treatment targets of T2D.

    UR - http://www.scopus.com/inward/record.url?scp=84940657237&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84940657237&partnerID=8YFLogxK

    U2 - 10.1093/hmg/ddv232

    DO - 10.1093/hmg/ddv232

    M3 - Article

    VL - 24

    SP - 5330

    EP - 5344

    JO - Human Molecular Genetics

    JF - Human Molecular Genetics

    SN - 0964-6906

    IS - 18

    M1 - ddv232

    ER -